Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea

OBJECTIVE: Long-acting injectable (LAI) antipsychotics, such as paliperidone palmitate (PP), are known to improve treatment adherence in patients with schizophrenia, which can lead to reductions in relapse and hospitalization rates. However, relatively few studies have demonstrated the economic impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dasom, Lee, Boung Chul, Choi, Soo-Hee, Kang, Do-Hyung, Jon, Duk-In, Jung, Myung Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242100/
https://www.ncbi.nlm.nih.gov/pubmed/32329310
http://dx.doi.org/10.9758/cpn.2020.18.2.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242100/
https://www.ncbi.nlm.nih.gov/pubmed/32329310
http://dx.doi.org/10.9758/cpn.2020.18.2.303

Ejemplares similares